The Worldwide Market Landscape for Exosomes: Research and Translational OpportunitiesTuesday, 3 September 2013 at 10:35 Add to Calendar ▼2013-09-03 10:35:002013-09-03 11:35:00Europe/LondonThe Worldwide Market Landscape for Exosomes: Research and Translational OpportunitiesMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com SELECTBIO has been tracking the qualitative and quantitative trends and opportunities in the exosomes and microvesicles marketplace. In this presentation, I provide an up-to-date snapshot of this evolving marketplace excerpted from SELECTBIO's various market reports on this topic. Presented are technologies for exosome analysis, segmentation of the exosome research market, market penetrance of various approaches for exosome study, disciplines/disease areas where exosome research is currently being carried out, and sizes of some of the market segments in this space—both from a basic research and a translational standpoint. Mapping the Market for Cancer Biomarkers, Epigenetic, and miR BiomarkersTuesday, 3 September 2013 at 10:45 Add to Calendar ▼2013-09-03 10:35:002013-09-03 11:35:00Europe/LondonThe Worldwide Market Landscape for Exosomes: Research and Translational OpportunitiesMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com SELECTBIO has been tracking the marketplace for various emerging biomarker classes, most notably epigenetic biomarkers and microRNA biomarkers. In this presentation, I will frame the technology trends and market landscape for these novel classes of cancer biomarkers, and frame the opportunity in terms of "hotspots" of research and commercial activity. Mapping the Market for Cancer Biomarkers, Epigenetic, and miR BiomarkersTuesday, 3 September 2013 at 10:45 Add to Calendar ▼2013-09-03 10:35:002013-09-03 11:35:00Europe/LondonThe Worldwide Market Landscape for Exosomes: Research and Translational OpportunitiesMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com SELECTBIO has been tracking the marketplace for various emerging biomarker classes, most notably epigenetic biomarkers and microRNA biomarkers. In this presentation, I will frame the technology trends and market landscape for these novel classes of cancer biomarkers, and frame the opportunity in terms of "hotspots" of research and commercial activity. |